$GL

Raymond James reiterated a Strong Buy rating and $208 price target for Globe Life (GL) after meetings with its leadership. The company expects excess cash flows of $850-950M in 2027, up from $600-700M in 2026, and has an 11% free cash flow yield. GL reported Q3 2026 net operating income of $4.84 per diluted share, missing estimates, but revenue rose to $1.6B, beating forecasts. Analysts have mixed reviews, with some lowering targets due to medical claims concerns.

Globe Life Inc. (GL) declared a quarterly dividend of $0.33 per share, payable on February 1, 2027, to shareholders of record as of January 8, 2027. The company is a holding company specializing in life and supplemental health insurance.

Globe Life executives discuss long-term strategies. They highlight stable bond holdings to weather economic downturns, with low exposure to risky assets. Long-dated policies provide steady cash flows for dividends and buybacks. Management expects mid- to high-single-digit sales growth by 2027, driven by agency expansion and product repricing.

Globe Life's EVP and Chief Strategy Officer, Michael Majors, sold 14,377 shares at $154.48 per share, totaling $2.22M. He now directly owns 39,141 shares, according to an SEC filing.

MAJORS MICHAEL CLAY (EVP - Chief Strategy Officer) sold 14,377 shares of GLOBE LIFE INC. (GL) at $154.48 ($2.22M total) on 2026-10-23.

JPMorgan reduced its price target for Globe Life from $195 to $190. Separately, Keefe Bruyette & Woods cut its target to $182 from $190. Globe Life's stock is currently trading at $156.72, up 1.24% on the day but down 8.28% year-to-date.

Wells Fargo reduced its price target for Globe Life (NYSE:GL) to $180 from $191, citing expected pressure on health unit earnings. The firm lowered EPS estimates due to challenges in health underwriting and elevated Medicare Supplement claims. Globe Life shares fell 8% on Friday. The company reported Q3 2026 net operating income of $4.84 per diluted share, missing estimates, despite revenue growth. Piper Sandler downgraded GL to Neutral with a $165 price target, citing medical claims volatility.

Bloom Energy (BE) fell 8% despite a 138.9% revenue increase and EPS beat, due to concerns over future revenue and capital expenditure. Globe Life (GL) dropped 8% after reporting 5.3% revenue growth and warning of FY 2026 headwinds. Comfort Systems (FIX) declined 9.26% despite strong earnings and revenue growth, citing higher material costs.

Wall Street analyst research calls for Friday include upgrades for Hess Midstream LP (HESM) to Outperform, MSC Industrial (MSM) to Overweight, and SpaceX (SPCX) to Buy. Downgrades include Deckers Outdoor (DECK) to Underweight, Globe Life (GL) to Neutral, and NVR (NVR) to Underperform. Initiations include Guardant Health (GH) and Natera (NTRA) with Buy ratings. Markets saw declines, with Nasdaq down 2.6% and Treasury yields dropping sharply.

TD Cowen reduced its price target for Globe Life to $215 from $225. The stock is currently trading at $168.41, with a 5-day change of -0.71% and a year-to-date change of +20.41%. Piper Sandler also downgraded Globe Life to Neutral with a $165 price target.